Recent 8-K filings for PVLA

Each filing is summarized by an LLM — headline, three bullets, event type. The source document on EDGAR is one click away. See methodology.

• May 13, 2026 11:30 UTC other_material item 8.01

  Palvella Therapeutics approved to uplist to Nasdaq Global Market on May 13

source · PVLA on sec.gov